Aren't the options double hormone blockade or triplet? Or if BRCA then perhaps PARPi? But you said ADT with optional...

Prostate CancerOctober 27, 2025Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Question asked:

Aren't the options double hormone blockade or triplet? Or if BRCA then perhaps PARPi? But you said ADT with optional double hormone blockage. No triplet and no genetic testing for possible targeted therapies? Is that from NCCN?

Let me clarify the current guidelines for advanced prostate cancer treatment options:

According to the NCCN Guidelines (2023):

  1. Genetic testing is actually recommended for all patients with metastatic prostate cancer to identify actionable mutations (including BRCA1/2)
  2. For metastatic hormone-sensitive prostate cancer (mHSPC), the preferred regimens include:
  • ADT + Abiraterone
  • ADT + Docetaxel
  • ADT + Enzalutamide
  • ADT + Apalutamide
  • ADT + Darolutamide

The ASCO Guidelines (2023) specifically endorse "triplet therapy" combining:

  • ADT + Novel Hormonal Agent (like enzalutamide/abiraterone) + Docetaxel for high-volume mHSPC

Regarding PARP inhibitors: The NCCN Guidelines indicate that for patients with mutations in homologous recombination repair genes (like BRCA1/2), PARP inhibitors (olaparib or rucaparib) are appropriate options after progression on initial therapy.

You are correct that I should have mentioned:

  1. The importance of genetic testing
  2. Triplet therapy as an option for eligible patients
  3. The potential role of PARP inhibitors for those with relevant mutations

Always consult with your oncologist about which approach is most appropriate for your specific situation, as factors like disease volume, genetic profile, and overall health influence treatment selection.

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →